The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?
Open accessAbstract
The rapid-acting antidepressant and antisuicidal effects of the anesthetic ( R , S )-ketamine, an N -methyl-d-aspartate receptor (NMDAR) antagonist, is an important discovery in depression research (1). However, the precise molecular mechanisms underlying ( R , S )-ketamine’s antidepressant actions remain unknown. Naltrexone, an opioid receptor antagonist, blocked the rapid antidepressant and antisuicidal effects of ( R , S )-ketamine in treatment-resistant patients with depression (2, 3). Although the sample size was small ( n = 7), the authors concluded that opioid receptor activation is required for the observed ( R , S )-ketamine effects. In contrast, some reports suggest that depressed patients who experience antidepressant effects of ( R , S )-ketamine lack opioid systems (4, 5 … [↵][1]1Email: hashimoto{at}faculty.chiba-u.jp. [1]: #xref-corresp-1-1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably however, whereas glutamatergic neurotransmission appears critical to the therapeutic efficacy of these compounds, whether direct NMDAR antagonism is primarily responsible for the ultimate effects is very much unsettled [74].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519
Ketamine: A Paradigm Shift for Depression Research and Treatment
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.005 · Cited by 455
The recent progress in animal models of depression
Wang, Q., Timberlake, M. A., Prall, K., & Dwivedi, Y. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.008 · Cited by 370
Hashimoto, K. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12902 · Cited by 335
Self-citationYang, C., Yang, J., Luo, A., & Hashimoto, K. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0624-1 · Cited by 190
Self-citationAttenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
Williams, N. R., Heifets, B. D., Bentzley, B. S., Blasey, C., Sudheimer, K. D., Hawkins, J., Lyons, D. M., & Schatzberg, A. F. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0503-4 · Cited by 174
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
Klein, M. E., Chandra, J., Sheriff, S., & Malinow, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916570117 · Cited by 156
Yoon, G., Petrakis, I. L., & Krystal, J. H. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3990 · Cited by 155
Zhang, K., Fujita, Y., Chang, L., Qu, Y., Pu, Y., Wang, S., Shirayama, Y., & Hashimoto, K. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0571-x · Cited by 104
Self-citationLack of Opioid System in the Antidepressant Actions of Ketamine
Zhang, K., & Hashimoto, K. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.11.006 · Cited by 71
Self-citation
Cited by
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei, Y., Chang, L., & Hashimoto, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01121-1 · Cited by 248
Self-citationMartinotti, G., Chiappini, S., Pettorruso, M., Mosca, A., Miuli, A., Carlo, F. D., d’Andrea, G., Collevecchio, R., Muzio, I. D., Sensi, S. L., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11070856 · Cited by 125
“inhibition alone could play a major role in the antidepressant effects of (R,S)-ketamine, opening the door for future studies and major developments [27].”
BackgroundArketamine, a new rapid-acting antidepressant: A historical review and future directions
Zhang, J.-C., Yao, W., & Hashimoto, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109219 · Cited by 97
“Collectively, it is likely that arketamine would be a new rapid-acting antidepressant without the side effects of esketamine (Hashimoto, 2016b, 2019, 2020a; Yang et al., 2019; Wei et al., 2020, 2022a; Zhang and Hashimoto, 2019a).”
InfluentialSelf-citationKetamine and its metabolites: Potential as novel treatments for depression
Zhang, K., Yao, Y., & Hashimoto, K. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109305 · Cited by 72
Self-citation(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
Wang, X., Yang, J., & Hashimoto, K. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104762 · Cited by 62
“Subsequent studies confirmed the robust antidepressant and anti-suicidal effects of intravenous (R,S)-ketamine (0.5 mg/kg) in treatment-resistant patients with MDD or bipolar disorder (Diazgranados et al., 2010; Fava et al., 2020; Su et al., 2017; Wilkinson et al., 2018; Zarate et al., 2006).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Hashimoto, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Hashimoto, Kenji
- ORCID
- Hashimoto, Kenji
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2020-05-19
- Volume
- 117
- Issue
- 21
- Pages
- 11200-11201
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC7260938
- OpenAlex
- W3027868414
- Cited by
- 19
- References
- 10
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 2 · 2020: 1
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Agency for Medical Research and Development (JP19dm0107119)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- ketamine, antidepressant effects, NMDA receptor, opioid receptors, depression
- MeSH terms
- Animals, Antidepressive Agents, Depression, Ketamine, Receptors, Opioid, Rodentia, N-Methylaspartate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are NMDA and opioid receptors involved in the antidepressant actions of ketamine? https://app.cochat.ai/papers/10.1073/pnas.2001264117
- The paper
- Hashimoto, K. (2020). Are NMDA and opioid receptors involved in the antidepressant actions of ketamine? Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2001264117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.